ArticleASM case reports2026
Septic arthritis caused by
Article in ASM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Case Summary: An 84-year-old man with multiple comorbidities presented with acute left shoulder pain, fever, and chills. Synovial fluid aspiration yielded turbid fluid containing calcium pyrophosphate dihydrate crystals, while Gram stain was negative. Despite empiric broad-spectrum antibiotics, his symptoms persisted, requiring surgical irrigation and debridement. Cultures from the joint aspirate and drain revealed β-hemolytic, mucoid colonies of gram-positive cocci (Lancefield group C), identified as SESZ by Vitek 2, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and whole-genome sequencing. Interestingly, the isolate had an atypical biochemical phenotype, i.e., it could not ferment sorbitol. Antimicrobial therapy was changed to intravenous ceftriaxone according to susceptibility testing, resulting in subsequent clinical improvement. Conclusion: Although rare, SESZ should be considered in the differential diagnosis of septic arthritis, particularly in elderly patients, even in the absence of clear zoonotic exposure. Timely recognition, adequate surgical drainage, and prolonged targeted antimicrobial therapy are essential for favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.